Body contouring, fat freezing to liposuction.

The safety file: "liposuction alone had a major complication rate of 0.7% with hematoma (0.15%), pulmonary complications (0.1%), infection (0.1%), and confirmed venous thromboembolism (0.06%)", with combined procedures (relative risk 4.81), age, BMI and hospital setting as independent predictors (Kaoutzanis 2017); the tumescent survey (Hanke 1995); large-volume liposuction averaging 7.7 litres with "3.35%" major complications — transfusion 2.89%, pulmonary embolism 0.18%, haematoma 0.16%, necrotising fasciitis 0.13% — and 11.6% minor, seroma commonest (Kanapathy 2021); tumescent lidocaine safe to 55 mg/kg with peak plasma levels at four to eight hours (Ostad 1996). The durability: at 8.9 years, surgeon and blinded evaluators scored volume and laxity significantly improved and "85.7% of the patients would recommend liposuction to their friends and family members" (Lipp 2020). The technique comparisons: a randomised trial found 980 nm laser-assisted lipolysis reduced submental fat thickness more than liposuction with higher satisfaction (Valizadeh 2016), while three studies found no advantage for a 10 W 1,064 nm laser over liposculpture alone and intra-operative burns in 2 of 20 patients with a higher-power combined device (Woodhall 2009).

Strong, graded on complication databases and outcome series rather than sham trials, because nobody randomises a flank against nothing; the double chin and upper arms guides grade their regional versions moderate on thinner regional data. The caveats are physiological: the compensatory visceral-fat rise without exercise (Benatti 2012), the transient effect on weight (Seretis 2015), and skin that hangs afterwards if it did not recoil before.

The databases: "1,012 (4.0 percent overall rate versus 1.4 percent in other aesthetic surgery procedures)", of which "31.5 percent were hematomas, 27.2 percent were infections and 20.2 percent were suspected or confirmed venous thromboembolism", with male sex, age over 55, BMI of 30 or more, multiple procedures and hospital setting as risk factors (Winocour 2015); an overall complication rate of 2.1% across seven abdominoplasty types, "fleur-de-lis abdominoplasty having the highest", with underweight, morbid obesity, diabetes and male sex as risks (Chaker 2024). Seroma: progressive-tension and quilting sutures cut it to an occurrence ratio of 0.306 in a meta-analysis of ten randomised trials and other studies (Liao 2024; Ardehali 2017). Clots: abdominoplasty "has the highest occurrence of VTE among aesthetic procedures", higher with liposuction, circumferential procedures, obesity and hormone therapy (Mittal 2020), and 58% of the clots in an outpatient database were abdominoplasties (Keyes 2018). The pay-off: in post-bariatric patients the abdominal appearance score rose from 13 to 90 and overall body image from 24 to 67 at a year, unaffected by minor complications (Paul 2020).

Strong, as the operation with the most patients and the clearest indication on this page: skin that hangs, a rectus separation, and a weight that has been stable for six to twelve months. Weight regain afterwards averaged 7.6% in non-bariatric and 11.8% in post-bariatric patients over 43 months, which "should not contend with the psychological benefit" but does change the contour (Henderson 2023). Muscle separation without loose skin is a different problem, and the electromagnetic row below has numbers for it.

The chin literature is the best in body contouring because it has a licensed drug and a pivotal device trial: submental cryolipolysis in 60 patients gave a 2.0 mm ultrasound fat reduction, 91% correct identification of baseline photographs by blinded physicians and 83% satisfaction (Kilmer 2016); 3D analysis measured 22.3 cm³ of volume lost at twelve weeks (Jain 2020); the meta-analysis of eight studies and 206 patients pooled "a mean reduction in submental fat thickness of −2.78 mm and volume of −19.57 cm³" (Do 2025); sequential cryolipolysis then deoxycholic acid gave every patient with extreme submental fat at least one grade and 71% two grades (Jalian 2022); the histology of the drug shows adipocyte lysis, inflammation and septal thickening confined to the fat (Walker 2020).

Strong, as the double chin guide grades deoxycholic acid and moderate as it grades cryolipolysis and liposuction; that guide and the neck guide sort the fat above the muscle from the fat below it, the platysma bands and the loose skin, and the mesotherapy guide grades the drug. A submental paradoxical hyperplasia needed a deep-plane neck lift to correct in one 2025 report (Zimmerman 2025).

Cryolipolysis: the systematic review of 19 studies found "average reduction in caliper measurement ranged from 14.67 percent to 28.5 percent" and by ultrasound "from 10.3 percent to 25.5 percent", no effect on lipids or liver tests, and "paradoxical adipose hyperplasia was described in one patient" (Ingargiola 2015); the 518-patient series found "23% reduction in fat layer thickness at 3 months", 73% satisfaction, and the abdomen, back and flanks the most effective sites (Dierickx 2013); the 2025 meta-analysis of 30 studies pooled an abdominal circumference change of −3.56 cm and suprailiac fat thickness of −5.22 mm at twelve weeks with 80.4% satisfaction, and adverse events of numbness in 49.5%, erythema 44.5%, oedema 30.5%, pain 28.8% and hyperpigmentation 2% (Ravindran 2025); the contralateral-control 3D trial (Garibyan 2014); a plastic-surgery practice's 1,785 treated sites with three cases of transient pain and no adverse events (Stevens 2013). Focused ultrasound: −2.44 cm against sham (Jewell 2011) and −2.3 cm at twelve weeks across five treatment techniques (Robinson 2014). The 1,060 nm laser: fat layer down 2.65 mm at twelve weeks with blinded evaluators picking the after-photograph 95% of the time, in all skin types (Bass 2018). Radiofrequency: 24% and 22% ultrasound fat reduction of abdomen and flanks in a single-blinded pilot (Somenek 2021).

Moderate, in line with the upper arms and double chin guides' grade for cryolipolysis. The arithmetic is honest: a 25 mm pinch becomes a 19–20 mm pinch after a cycle, visibly in a slim person and invisibly under an overweight one, with the paradoxical-hyperplasia risk of Part 03 attached to every cycle.

The inner-thigh trials: 42 patients who held their weight within five pounds, "independent photo review from 3 blinded physicians found 91% correct identification of baseline clinical photographs", ultrasound fat reduction of 2.8 mm, circumference −0.9 cm, 93% satisfied and no serious adverse events (Zelickson 2015); the prototype study with 83% attaining some reduction and a normalised mean of 20% or 3.3 mm (Boey 2014); a rotational radiofrequency device with 6% thigh fat-layer reduction and 2% off thigh contours (Santos 2024); and the full-body electromagnetic-plus-radiofrequency MRI series with fat thickness down 17.57 mm in the saddlebag region and 12.43 mm in the inner thighs, and 2.8–3.6 cm off thigh circumferences (Katz 2023). The systematic review of focused ultrasound reports "effective noninvasive lifting" of the abdomen and thighs with fewer than 5% transient side effects and no standard protocol (Haykal 2025).

Moderate. The inner thigh is the site where skin quality decides the result: a slim thigh with a discrete pad responds; a thigh whose skin has already lost its recoil is a thigh-lift question, graded below, and the cellulite guide explains why fat removal can make the dimples more visible rather than less.

The imaging series: "average 18.6% reduction of adipose tissue thickness, 15.4% increase in rectus abdominis muscle thickness, and 10.4% reduction in rectus abdominus separation" at two months, more in patients of normal BMI, with a 3.8 cm sub-umbilical circumference change and no weight change (Kinney 2019); one-year follow-up with 14.6% less fat, 19.1% thicker muscle and 10.5% less diastasis "not related to weight fluctuations" (Kinney 2020); postpartum women with 20.2% fat reduction, 21.3% muscle increase and 22.7% less separation at three months (Jacob 2020); gluteal muscle volume up 10.8% at one month and 13.2% at three with "visible buttock lifting" and fat unaffected (Palm 2021), and 24.7% with synchronised radiofrequency against 15.9% without (DiBernardo 2023). The controlled trial: radiofrequency and electromagnetic stimulation together against sham, fat thickness −20.5% at one month and −28.3% at three, rectus thickness +21.5% and +24.2%, maintained at six months, "whereas the sham group showed no significant changes" (Samuels 2022). Combined with cryolipolysis, the pairing scored highest on blinded photographs in a feasibility study (Kilmer 2020).

Moderate for the abdomen and buttocks, on one sham-controlled trial and a consistent set of imaging series against two independent reviews' scepticism (Swanson 2023; Kohan 2024); the upper arms guide keeps the arm version at emerging on its single uncontrolled study. Two millimetres of rectus muscle is what a few months of training produces, and like training it is lost without maintenance; a separation wider than a few centimetres with loose skin is an abdominoplasty.

The task-force report: 692 surgeons, 198,857 cases, "32 fatalities from pulmonary fat emboli as well as 103 nonfatal pulmonary fat emboli", 3% of surgeons with a patient death, deep-muscle injection associated with the fatal and non-fatal emboli, and "twenty-five fatalities were confirmed in the United States over the last 5 years" (Mofid 2017). The follow-up survey two years after the recommendations: pulmonary fat embolism "1 in 2492 compared with 1 in 1030 reported in 2017", mortality trending "from 1 in 3448 in 2017 to 1 in 14,952 in 2019", deep-muscle injection down from 13.1% to 0.8% of surgeons, and cannulas of 4.1 mm or more up from 4.1% to 29.8% (Rios 2020). The 2026 review contrasts the gluteal veins and volumes with breast and facial lipofilling's lower embolism risk and calls for strict subcutaneous injection, ultrasound guidance and registries (Aad 2026); the safety review notes larger graft volumes bring more fat necrosis (Chopan 2019). The non-surgical option: gluteal muscle volume up 13.2% at three months on MRI (Palm 2021; DiBernardo 2023).

Moderate for the augmentation itself, graded on series and surveys rather than trials, and the reason the safety row exists. A surgeon who injects only under the skin, with ultrasound, through a large cannula, in a facility that can treat an embolus, is the whole of the risk reduction; a "BBL" at a discount abroad is the whole of the risk.

The prospective series: 50 patients with a mean excess-weight loss of 86%, "a total of 35 (70%) patients developed at least one complication", 10% needing surgical revision, dehiscence in 60% and seroma in 34%, complications related to the maximum BMI reached and to age (Kitzinger 2013). The thigh: "complications were observed in 191/447 patients (42.72%)", mostly dehiscence (18.3%) and seroma (8.1%), with no thromboembolism or sepsis in the reviewed series (Sisti 2015); the post-bariatric thigh-lift review of 17 articles and 496 patients finds the liposuction-assisted inner thigh lift with combined scars "effective and versatile for most patients" (Susini 2024). The pay-off and the weight: body-image scores from 24 to 67 (Paul 2020); post-bypass patients gained 2.3 lb after contouring against 22 lb for dieters (Shermak 2008); 11.8% regain over 43 months in the post-bariatric cohort (Henderson 2023). On a GLP-1 drug the same questions apply with a plateau at 8–12 months and a regain of more than half after stopping (Garbaccio 2025).

Moderate: a surgery that works, in the sense of removing the skin and restoring a body the patient can live in, at complication rates that would be unacceptable anywhere else in aesthetic surgery and are accepted here because nothing else does the job. Weight stable for a year, nutrition corrected, smoking stopped, and a surgeon who does these every week are the conditions; the upper arms guide grades the arm lift on the same terms.

The arm evidence: one cryolipolysis cycle with a flat applicator gave "a mean reduction in fat layer thickness of 15.3%, corresponding to 2.03 mm" at eight weeks (Lee 2016); electromagnetic stimulation with radiofrequency reduced arm fat 25.5% and increased muscle 23.9% on MRI at three months in 25 completers with 85% satisfied (Jacob 2023); radiofrequency-assisted liposuction reduced anterior and posterior arm skin surface 15.0% and 13.1% at one year against 10.9% and 8.1% for aggressive superficial liposuction (Chia 2015); the brachioplasty meta-analysis of 29 studies and 1,578 patients found aberrant scarring 9.9%, recurrence 7.8%, dehiscence 6.8%, seroma 5.9%, infection 3.6%, nerve complications 2.5% and lymphoedema 2.5% (Aljerian 2022).

Moderate across the board, as the upper arms guide grades each of them with the self-check that sorts fat from skin from muscle; this row exists so that the arm is not missing from the body map.

The one measurement: "a VAT reduction of 17.8% on average at 3-month follow-up, maintaining the results up to 6 months" on MRI after electromagnetic-plus-radiofrequency treatment in a retrospective analysis with no control group (Kent 2023). Against it, the physiology: liposuction of subcutaneous abdominal fat triggered a 10% compensatory rise in visceral fat within six months in the randomised trial's non-exercising arm (Benatti 2012), and the effect of lipectomy on weight and fat mass faded within months in the systematic review (Seretis 2015). Spot reduction by exercise, long dismissed, did appear in a randomised trial in which abdominal endurance exercise reduced trunk fat by 7% against no change with treadmill running at matched energy expenditure (Brobakken 2023).

Emerging for the device claim; the treatment is weight loss, whose drugs are covered in the 50s guide and whose consequences for skin are in the tightening guide. A clinic that offers a fat-freezing cycle for a belly it could not pinch is selling the cycle.

The numbers: weight "did not change significantly (average −0.5 lb)" in the electromagnetic MRI series (Kinney 2019) and "no studies reported weight change before and after treatment" in the systematic review (Kohan 2024); "mean weight change was +0.1 lb" in the laser trial (Bass 2018); the low-level laser group "demonstrated a gain of 0.31 total inches" in the two weeks after treatment ended (Jackson 2009); lipectomy's effect on weight and fat mass was "transient", present at one to two months and absent at three to twenty (Seretis 2015). The cryolipolysis meta-analysis did pool a BMI change of −1.8 at twelve weeks across uncontrolled studies (Ravindran 2025), which in the absence of controls says more about who books a course of fat freezing than about the device.

Limited. The sequence that works is the opposite one: lose the weight, hold it for six to twelve months, then contour what is left — the skin with surgery, the pockets with a device or a cannula. The cellulite guide and sauna guide grade the other weight-loss claims made in the same rooms.

Cellulite is fibrous septa tethering the skin over lobulated fat; taking the fat out from under a tethered skin leaves the tethers and a looser envelope. The non-invasive fat trials measured fat thickness and circumference, not dimples (Ingargiola 2015; Wolska 2023), and the one body-contouring study to report dermal changes found only non-significant trends in echogenicity with a 6% rise in thigh dermal thickness (Santos 2024).

Limited, as the cellulite guide grades fat removal for dimples; that guide grades what does work, and the tightening guide the ultrasound-plus-biostimulator combination that improved cellulite scores by 4.5 points in one study.